News2 mins ago
Phio Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
MARLBOROUGH, Mass., May 11, 2023 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to...
